The blood thinner Pradaxa has allegedly been linked to 1,000 fatalities and thousands of other adverse events, for which it has already paid hundreds of millions in damages for.
Immediately after its FDA approval in 2010, some patients experienced serious side effects, including hemorrhaging. Though this was a widespread problem, Pradaxa lacked an antidote for uncontrollable bleeding until October 2015 when Praxbind became available—five years after Pradaxa was first prescribed to patients.
Documents reveal that Pradaxa manufacturer Boehringer Ingelheim allegedly failed to disclose to the FDA that Pradaxa resulted in higher occurrences of hemorrhaging after the drug was cleared. Though they conducted multiple studies, documents suggest that the company only shared the most favorable results for approval.
Boehringer Ingelheim’s negligence has resulted in thousands of wrongful death and personal injury lawsuits. If you or a loved one took Pradaxa and suffered uncontrollable bleeding, you may be entitled to compensation.
Boehringer Ingelheim Settles 4,000 Lawsuits for $650 Million (2014)
Soon after Pradaxa hit the market, wrongful death and personal injury lawsuits were filed for its dangerous side effects. In August 2012, 4,000 state and federal lawsuits were combined in a multidistrict litigation.
Boehringer Ingelheim resisted litigation, and paid the price. In 2013, the company was hit with an almost $1 million fine for discovery abuses, including failure to cooperate and alleged negligence for more than 500,000 lost documents.
In May 2014 after mounting public and media pressure, Boehringer Ingelheim agreed to pay $650 million to settle the claims, averaging $162,500 for each claimant.
Boehringer Ingelheim Faced With Hundreds More Pending Claims
Though Pradaxa now has an antidote, Boehringer Ingelheim is still liable for the years when patients were vulnerable to uncontrollable bleeding. Pradaxa patients who weren’t part of the 2014 settlement continue to file lawsuits.
Zhensheng Liu (Pending)
Zhensheng Liu died in 2012 when a fall resulted in uncontrollable bleeding in his brain. The wrongful death lawsuit alleges that Pradaxa is to blame, and that Boehringer Ingelheim’s warnings about potential side effects were insufficient.
The trial is set for December 2016. Boehringer continues to deny Pradaxa’s responsibility and unsuccessfully attempted to dismiss the trial.
Americo Vari (Pending)
Pradaxa patient Americo Vari died from a brain hemorrhage that doctors couldn’t stop. The wrongful death lawsuit was filed by Americo’s wife, Adelaide, and blames Pradaxa for his death. The lawsuit was filed in Connecticut in August of this year.
Arnold R. Castillo and Linda Castillo (Pending)
Arnold Castillo was prescribed Pradaxa for stroke prevention and systemic embolism. He suffered from uncontrollable bleeding and resulting injuries, but thankfully survived. He and his wife, Linda Castillo, have since filed a lawsuit against the company.
Princess Fahnestock et al (Pending)
In May 2016, a class action lawsuit was filed in Missouri against Boehringer Ingleheim. Sixty-eight suffering Pradaxa patients and relatives from Missouri, Delaware, Connecticut, and Ohio make up the lawsuit, which accuses the company of crimes relating to the design, manufacture, testing, and promotion of Pradaxa.
Keith Love et al (Pending)
A class action lawsuit was filed in August 2016 in Missouri, representing 76 plaintiffs. The lawsuit accuses Pradaxa of failure to warn, design defect, negligence, misrepresentation, and wrongful death, among others.
ClassAction.com Can Help
If you were not part of the 2014 Pradaxa settlement, and you or a loved one were injured by the drug before Praxbind hit the market, you may be entitled to compensation. Personal injury and wrongful death lawsuits can recover damages for pain and suffering, medical bills, lost wages, and other financial losses.
ClassAction.com attorneys have recovered more than $2 billion for 200,000 clients, winning verdicts against large corporations like BMW and R.J. Reynolds Tobacco. Contact us today for a free, no-obligation legal review.